Related Experiment Videos
DNA copy number losses in human neoplasms
1Department of Medical Genetics, Haartman Institute University of Helsinki, Finland. sakari.knuutila@helsinki.fi
The American Journal of Pathology
|September 17, 1999
Summary
This review details recurrent DNA copy number losses across 73 human tumor types using comparative genomic hybridization. Frequent losses at specific chromosomal regions suggest key tumor suppressor and DNA repair genes involved in cancer development.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Recurrent DNA sequence copy number losses are hallmarks of human neoplasms.
- Comparative genomic hybridization (CGH) is a key technique for detecting these genomic alterations.
- Understanding these losses is crucial for identifying genes involved in tumorigenesis.
Purpose of the Study:
- To systematically review and tabulate recurrent DNA copy number losses across various human tumor types.
- To identify chromosomal regions frequently affected by deletions in cancer.
- To discuss the relevance of genes located in these deleted regions, including tumor suppressor and DNA repair genes.
Main Methods:
- Comprehensive literature review of 169 reports on comparative genomic hybridization.
- Tabulation of recurrent losses affecting chromosome arms in 73 distinct tumor types.
- Analysis of minimal common overlapping deleted regions across multiple tumor entities.
Main Results:
- Recurrent DNA copy number losses were identified in all chromosome arms, with varying frequencies.
- The most frequent losses were observed at 9p23-p24 (48%), 13q21 (47%), 6q16 (44%), and 6q26-q27 (44%).
- Specific chromosomal regions with high frequencies of loss implicate critical tumor suppressor and DNA repair genes.
Conclusions:
- Recurrent copy number losses are widespread in human cancers.
- The identified frequently deleted chromosomal regions are enriched for genes critical to cancer pathogenesis.
- This compilation provides a valuable resource for understanding the genetic basis of various tumor types.